SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-020783
Filing Date
2024-05-20
Accepted
2024-05-20 17:27:08
Documents
47
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 528041
2 ex31-1.htm EX-31.1 19489
3 ex31-2.htm EX-31.2 19663
4 ex32-1.htm EX-32.1 8796
5 ex32-2.htm EX-32.2 8698
  Complete submission text file 0001493152-24-020783.txt   3425534

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE tenk-20240331.xsd EX-101.SCH 28819
7 XBRL CALCULATION FILE tenk-20240331_cal.xml EX-101.CAL 26645
8 XBRL DEFINITION FILE tenk-20240331_def.xml EX-101.DEF 162383
9 XBRL LABEL FILE tenk-20240331_lab.xml EX-101.LAB 226166
10 XBRL PRESENTATION FILE tenk-20240331_pre.xml EX-101.PRE 195398
50 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 410006
Mailing Address 420 LEXINGTON AVE, SUITE 2446 NEW YORK NY 10017
Business Address 420 LEXINGTON AVE, SUITE 2446 NEW YORK NY 10017 (347) 627-0058
TenX Keane Acquisition (Filer) CIK: 0001851484 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41534 | Film No.: 24965975
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)